# A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers.

> **NCT00862667** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Treatment A
- **DRUG:** Treatment B
- **DRUG:** Treatment C

## Key facts

- **NCT ID:** NCT00862667
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2009-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00862667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00862667, "A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00862667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*